Boothbay Fund Management
AYLA

Boothbay Fund Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Boothbay Fund Management’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-68,237
Closed -$74K – 2779
2022
Q2 		$74K Hold
68,237
– – ﹤0.01% 2033
2022
Q1 		$272K Hold
68,237
– – 0.01% 1676
2021
Q4 		$581K Buy
68,237
+14,453
+27% +$143K 0.01% 952
2021
Q3 		$610K Buy
+53,784
New +$645K 0.02% 997

Other funds holding AYLA

Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Clear Street
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Boothbay Fund Management's AYLA Position: Q3 2022 in Review

Boothbay Fund Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q3 2022, closing a stake of 68,237 shares — an estimated $74K sold.

Boothbay Fund Management first reported a position in AYLA in Q3 2021 and held it in 4 quarters. The position peaked at $610K in Q3 2021. 14 funds tracked by Wall St. Rank hold AYLA as of Q3 2022.

  • Boothbay Fund Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 68,237 Ayala Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $74K.
  • Boothbay Fund Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Boothbay Fund Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $610K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.